Viridis Biopharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2000.
2000 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Viridis Biopharma Private Limited

Viridis Biopharma Private Limited, a active private limited company, was established on 06 June 2000 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2000PTC127016. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹3.42 Cr.

It upholds a compliant status. Employing 59 professional, Its leadership includes Anselm Julius Desouza (Director), Purnima Dilip Mehta (Director), Ashit Harshad Vora (Managing Director). Past directors included Purnima Dilip Mehta, Tejal Anirudh Mehta. It holds ₹28.60 Cr open charges and ₹17.29 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No. 1503, Universal Majestic,, P L Lokhande Marg, Chembur, Mumbai, Maharashtra, 400043.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2000PTC127016

  • Registration Number

    127016

  • Incorporation Date

    06 June 2000

  • Authorized Capital

    ₹6.00 Cr

  • Paid-Up Capital

    ₹3.42 Cr

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.00 Cr
  • Paid Up Capital ₹ 3.42 Cr
  • Company Age 25 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 28.60 Cr
  • Satisfied Charges ₹ 17.29 Cr
  • Revenue Growth **** 12.62%
  • Profit Growth **** -126.69%
  • Ebitda **** -3.28%
  • Net Worth -1.51%
  • Total Assets -7.62%
Company report

Viridis Biopharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Viridis Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Viridis Biopharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Anselm Julius Desouza Director 06 Jun 2000 Current
Purnima Dilip Mehta Director 01 Oct 2015 Current
Ashit Harshad Vora Managing Director 06 Jun 2000 Current
Anirudh Dilip Mehta Managing Director 06 Jun 2000 Current
Vishal Harshad Vora Director 01 Feb 2011 Current
Harshad Chhotalal Vora Director 06 Jun 2000 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Director 01 Oct 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Viridis Biopharma.

Viridis Biopharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.62% increase. The company also saw a substantial fall in profitability, with a 126.69% decrease in profit. The company's net worth dipped by a decrease of 1.51%.

Viridis Biopharma revenue growth over time
Viridis Biopharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 12.62%
*******
*******
*******
*******
Revenue from Operations
*******
 15.08%
*******
*******
*******
*******
Total Assets
*******
 -7.62%
*******
*******
*******
*******
Profit or Loss
*******
 -126.69%
*******
*******
*******
*******
Net Worth
*******
 -1.51%
*******
*******
*******
*******
EBITDA
*******
 -3.28%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Viridis Biopharma?

In 2023, Viridis Biopharma had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹286,000,000.00

Satisfied Charges

₹172,900,000.00

Charges Breakdown by Lending Institutions
  • Others : 28.60 Cr
Latest Charge Details
Date Lender Amount Status
23 Sep 2025 Others ₹11.25 Cr Open
08 Nov 2019 Others ₹17.35 Cr Open
28 Feb 2015 Standard Chartered Bank ₹1.21 Cr Satisfied
14 Nov 2014 Bank Of Baroda ₹5.36 Cr Satisfied
17 Nov 2006 Bank Of Baroda ₹2.60 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Viridis Biopharma?

Viridis Biopharma has a workforce of 59 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Viridis Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viridis Biopharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Viridis Biopharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Viridis Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    A charge with Others amounted to Rs. 11.25 Cr with Charge ID 101176762 was registered on 23 Sep 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 17.35 Cr registered on 08 Nov 2019 with Charge ID 100299376 was modified on 30 May 2025. was documented.

  • Balance Sheet

    Viridis Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was recorded as a recent event.

  • Charges

    A charge registered on 28 Feb 2015 via Charge ID 10552455 with Standard Chartered Bank was fully satisfied on 09 Nov 2023. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 17.35 Cr with Charge ID 100299376 was registered on 08 Nov 2019. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Viridis Biopharma Private Limited?

The CIN of Viridis Biopharma Private Limited is U24230MH2000PTC127016.

Where is Viridis Biopharma Private Limited headquartered?

Viridis Biopharma Private Limited is headquartered at Unit No. 1503, Universal Majestic,, P L Lokhande Marg, Chembur, Mumbai, Maharashtra, 400043.

When was Viridis Biopharma Private Limited incorporated?

Viridis Biopharma Private Limited was incorporated on 06 June 2000.

Who are the current directors of Viridis Biopharma Private Limited?

The current directors of Viridis Biopharma Private Limited are

What is the primary industry of Viridis Biopharma Private Limited?

The primary industry of Viridis Biopharma Private Limited is Manufacturing.

Is Viridis Biopharma Private Limited a listed company?

Viridis Biopharma Private Limited is unlisted.

What is the capital structure of Viridis Biopharma Private Limited?

The authorized capital of Viridis Biopharma Private Limited is ₹6.00 Cr, and the paid-up capital is ₹3.42 Cr.

What is the compliance status of Viridis Biopharma Private Limited?

The compliance status of Viridis Biopharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available